Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
J Cardiol. 2022 Mar;79(3):365-370. doi: 10.1016/j.jjcc.2021.11.004. Epub 2021 Dec 20.
Mechanical and electrical restoration by cardiac resynchronization therapy (CRT) with adaptive pacing algorithm (aCRT) in heart failure patients with a moderately wide (120-149 ms) QRS has not been fully evaluated. The purpose of this study was to investigate the therapeutic effect of aCRT compared with conventional biventricular CRT (BiV-CRT) regardless of QRS morphology.
Seventeen consecutive patients with a QRS ≥120 ms, regardless of morphology, underwent CRT device implantation with an aCRT pacing algorithm. Propensity score matched analysis was performed to evaluate the impact of aCRT on the improvement in mechanical and electrical parameters after CRT device implantation using historical controls (HC) from the clinical registry of BiV-CRT (START trial).
Left ventricular (LV) volume significantly decreased after CRT in all patients in both the aCRT and HC groups. The difference in relative reduction of LV end-systolic volume (LVESV) was not significantly different between the 2 arms. QRS shortening after CRT was significantly greater in the aCRT group than in the BiV-CRT group, and the difference was prominent in patients with a moderately wide QRS (120-149 ms). In patients with a moderately wide QRS, the relative reduction in LVESV [39 (29-47)% vs. 2 (-6-20)%, p = 0.04] and proportion of LV volume responders (90% vs. 38%, p = 0.04) were significantly greater in the aCRT group than in the HC group. The proportion of volume responders was not significantly different in patients with a wide QRS (≥150 ms).
The aCRT algorithm improved electrical and mechanical parameters in patients with a moderately wide QRS, regardless of QRS morphology.
对于 QRS 波时限在 120-149ms 之间的中度宽(120-149ms)的心力衰竭患者,采用心脏再同步治疗(CRT)的机械和电恢复与自适应起搏算法(aCRT)相结合的治疗效果尚未得到充分评估。本研究的目的是评估 aCRT 与传统双心室 CRT(BiV-CRT)的治疗效果,而不考虑 QRS 形态。
17 例 QRS 波时限≥120ms、无论形态如何的患者均采用 aCRT 起搏算法植入 CRT 装置。采用倾向性评分匹配分析,使用 BiV-CRT 临床注册研究(START 试验)的历史对照(HC)评估 aCRT 对 CRT 装置植入后机械和电参数改善的影响。
在 aCRT 和 HC 两组患者中,所有患者在 CRT 后左心室(LV)容积均显著减少。两组之间 LV 收缩末期容积(LVESV)相对减少的差异无统计学意义。CRT 后 QRS 波时限缩短在 aCRT 组明显大于 BiV-CRT 组,在 QRS 波时限中度宽(120-149ms)的患者中差异更为显著。在中度宽 QRS 患者中,aCRT 组的 LVESV 相对减少[39(29-47)%比 2(-6-20)%,p=0.04]和 LV 容量反应者的比例(90%比 38%,p=0.04)明显大于 HC 组。在 QRS 波时限较宽(≥150ms)的患者中,容量反应者的比例无显著差异。
aCRT 算法改善了 QRS 波时限中度宽的患者的电和机械参数,而不考虑 QRS 形态。